Biologics

Biologics is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Biologics, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Why watch Biologics

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Biologics news

The latest feed items from companies currently grouped under Biologics.

1. 01
   2026-10-05 08:00 EST

   ALVOMatvæla- og lyfjastofnun Bandaríkjanna (FDA) veitir viðbótarleyfi fyrir framleiðslu á hliðstæðunni við Humira í báðum framleiðslueiningum lyfjaverksmiðju Alvotech í Reykjavík

   Source: Alvotech

2. 02
   2026-10-05 08:00 EST

   ALVOFDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

   Source: Alvotech

3. 03
   2026-10-01 11:00 EST

   STTKShattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

   Source: Shattuck Labs

4. 04
   2026-10-01 06:00 EST

   RHHBYRoche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions

   Source: Roche Holdings AG

5. 05
   2026-10-01 05:00 EST

   RHHBYRoche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine

   Source: Roche Holdings AG

6. 06
   2026-09-30 05:00 EST

   RHHBYRoche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis

   Source: Roche Holdings AG

7. 07
   2026-09-29 05:00 EST

   PHARPharming announces CEO transition

   Source: Pharming Group

8. 08
   2026-09-25 14:30 EST

   PHARPharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

   Source: Pharming Group

9. 09
   2026-09-23 20:01 EST

   MDXGMIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter

   Source: MiMedx

10. 10
    2026-09-23 13:30 EST

    CHRSCoherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

    Source: Coherus BioSciences, Inc.

11. 11
    2026-09-23 05:15 EST

    RHHBYPositive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)

    Source: Roche Holdings AG

12. 12
    2026-09-23 05:00 EST

    RHHBYÄnderung im Verwaltungsrat von Roche

    Source: Roche Holdings AG

13. 13
    2026-09-23 05:00 EST

    RHHBYChange in Roche’s Board of Directors

    Source: Roche Holdings AG

14. 14
    2026-09-22 05:00 EST

    RHHBY[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and overweight or obesity

    Source: Roche Holdings AG

15. 15
    2026-09-22 05:00 EST

    PHARPharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026

    Source: Pharming Group

16. 16
    2026-09-21 15:45 EST

    RHHBYEuropean Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)

    Source: Roche Holdings AG

17. 17
    2026-09-18 10:45 EST

    RHHBYCHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis

    Source: Roche Holdings AG

18. 18
    2026-09-17 18:30 EST

    RHHBYRoche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases

    Source: Roche Holdings AG

19. 19
    2026-09-17 05:00 EST

    RHHBYRoche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study

    Source: Roche Holdings AG

20. 20
    2026-09-13 00:00 EST

    RHHBYRoche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer

    Source: Roche Holdings AG

Companies in Biologics

18 companies tagged with Biologics.

Frequently Asked Questions